TIM

(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol

Created:	2008-05-22
Last modified:	2021-03-01

Find Related PDB Entry
3 entries where TIM is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	45
Chiral Atom Count	1
Bond Count	46
Aromatic Bond Count	5

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
Synonyms	Timolol maleate
Systematic Name (OpenEye OEToolkits)	(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
Formula	C₁₃ H₂₄ N₄ O₃ S
Molecular Weight	316.42
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	OC(COc1nsnc1N2CCOCC2)CNC(C)(C)C
SMILES	CACTVS	3.341	CC(C)(C)NC[CH](O)COc1nsnc1N2CCOCC2
SMILES	OpenEye OEToolkits	1.5.0	CC(C)(C)NCC(COc1c(nsn1)N2CCOCC2)O
Canonical SMILES	CACTVS	3.341	CC(C)(C)NC[C@H](O)COc1nsnc1N2CCOCC2
Canonical SMILES	OpenEye OEToolkits	1.5.0	CC(C)(C)NC[C@@H](COc1c(nsn1)N2CCOCC2)O
InChI	InChI	1.03	InChI=1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3/t10-/m0/s1
InChIKey	InChI	1.03	BLJRIMJGRPQVNF-JTQLQIEISA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB00373
Name	Timolol
Groups	approved investigational
Description	Timolol is a nonselective beta-adrenergic antagonist given in an eye drop solution to reduce intraocular pressure, or pressure in the eyes.[L6724] It is also used in tablet form as a drug to treat hypertension.[L6727] Timolol was first approved by the FDA in 1978.[L6724] This drug is marketed by several manufacturers [L6736] and is an effective agent for the management of conditions such as open-angle glaucoma and hypertension.
Synonyms	Timololum Timolol hemihydrate Timolol Timolol anhydrous Timololo Timolol maleate (S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
Brand Names	Ag-dorzolamide Timolol Dorzolamide Hydrochloride and Timolol Maleate Med Timolol Liq Oph 0.25% Tim-Lat -PF Dorzolamide and Timolol Eye Drops BP Mint-latanoprost/timolol Rhoxal-timolol 0.25% Apo-travoprost-timolol Pq Latanoprost and Timolol Ophthalmic Solution Apo-travoprost-timop Pq Timolol maleate Timolol Maleate Ophthalmic Solution Med-dorzolamide-timolol Sandoz Timolol Beta-tim - 0.5% Liq Timolol-10 Tab 10mg Timolol-20 Tab 20mg Timoptic PMS-latanoprost-timolol Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution Jamp Brimonidine/timolol Dorzolamide Hydrochloride and Timolol Maleate ophthalmic Solution Sandoz Travoprost / Timolol Pq Med Timolol Liq Oph 0.5% Dorzolamide Hydrochloride Timolol Maleate Timpilo 2 Cosopt PF Timolol-5 Tab 5mg Tim-Dor PF Timolide Tab M-latanoprost-timolol Timolol hemihydrate Teva-latanoprost-timolol Teva-latanoprost/timolol Dorzolamide Hydrochloride Timolol Maletae Xalacom Blocadren Dorzolamide and Timolol Apo-dorzo-timop Apo-timop Gel Priva-dorzolamide-timolol Riva-dorzolamide/timolol Mint-dorzolamide/timolol Nu-timolol Tab 20mg Van-dorzolamide-timolol Teva-timolol Brimonidine tartrate and Timolol maleate Ratio-timolol Maleate 0.25% Tim-Dor-Lat Apo-brimonidine-timop Timolol Maleate Ophthalmic Gel Forming Solution, 0.5% Apo-latanoprost-timop Ratio-timolol Maleate 0.5% Timoptic-XE Timolol Maleate Ophthalmic Gel Forming Solution 0.5% Apo-timop Blocadren Tab 10mg Sandoz Latanoprost/timolol Cosopt Dorzolamide-timolol Nu-timolol Tab 5mg Dorzolamide Hydrochloride-Timolol Maleate Ophthalmic Solution Sterile Ophthalmic Solution Timolol Solution - 0.5% Mylan-timolol Brimonidine Tartrate and Timolol Maleate M-dorzolamide-timolol Med-latanoprost-timolol Dorzolamide hydrochloride and timolol maleate Timolol Maleate Ophthalmic Gel Forming Solution 0.25% Timolol Dorzolamide Hydrochloride-timolol Maleate Novo-timol Liq 0.5% Nu-timolol Tab 10mg Mylan-dorzolamide/timolol Sandoz Dorzolamide/timolol Jamp Dorzolamide-timolol Timolol Maleate Timolol Maleate Ophthalmic Gel Forming Solution, 0.25% DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE Timolol GFS Timpilo 4 Timolol Maleate Ophthalmic Gel Forming Solution Combigan Azarga Teva-dorzotimol Mylan-latanoprost/timolol Sandoz Brimonidine / Timolol Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution Duokopt Dorzolamide HCl and Timolol Maleate Duotrav Pq PMS-timolol Dorzolamide-timolol PF Timoptic PF Istalol BRIMONIDINE TARTRATE and TIMOLOL MALEATE Novo-timol Liq 0.25% Tim-Brim-Dor-Lat Beta-tim - 0.25% Liq Tim-Brim-Dor PF Cosopt Preservative-free Dorzolamide Hydrochloride and Timolol Maleate Preservative Free Latanoprost / Timolol Timoptic in Ocudose Blocadren Tab 5mg Act Dorzotimolol Rhoxal-timolol 0.5% Timolol Hemihydrate Blocadren Tab 20mg PMS-dorzolamide-timolol Jamp-timolol Ganfort Timolol Solution - 0.25% Riva-latanoprost/timolol Dom-timolol Duotrav Dorzolamide HCl /Timolol Maleate Jamp-latanoprost/timolol Dorzolamide Hydrochloride-Timolol Maleate Timolol Maleate-EX Brimonidine Tartrate/Timolol Maleate Dorzolamide Hydrochloride and Timolol Maleate ophthalmic Betimol T-LO Odan-timolol
Indication	Ophthalmic timolol is indicated for the treatment of increased intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The oral form of this drug is used to treat high blood pressure.[L6724,L6727] In certain cases, timolol is used in the prevention of migraine headaches.[A179530,L6742]
Categories	Adrenergic Antagonists Adrenergic beta-Antagonists Agents causing hyperkalemia Alcohols Amines Amino Alcohols Antiarrhythmic agents Antiglaucoma Preparations and Miotics Antihypertensive Agents Beta Blocking Agents and Thiazides Beta Blocking Agents, Non-Selective Beta Blocking Agents, Non-Selective, and Thiazides Bradycardia-Causing Agents Cardiovascular Agents Cytochrome P-450 CYP2C19 Substrates Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted EENT Drugs, Miscellaneous Hypotensive Agents Morpholines Ophthalmologicals Oxazines P-glycoprotein substrates Potential QTc-Prolonging Agents Propanolamines Propanols QTc Prolonging Agents Sulfur Compounds Thiadiazoles Thiazoles
ATC-Code	C07AA06 S01ED51 C07BA06 C07DA06 S01ED01
CAS number	26839-75-8

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
Beta-1 adrenergic receptor	MGAGVLVLGASEPGNLSSAAPLPDGAATAARLLVPASPPASLLPPASESP...	unknown	antagonist
Beta-2 adrenergic receptor	MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFG...	unknown	antagonist
Cytochrome P450 2C19	MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV...	unknown	substrate
Cytochrome P450 2D6	MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVD...	unknown	substrate
ATP-dependent translocase ABCB1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource Name	Reference
Pharos	CHEMBL499
PubChem	33624
ChEMBL	CHEMBL499
ChEBI	CHEBI:9599
CCDC/CSD	JEYFEY10

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.

Prepare Data

Validate Data

Deposit Data

Help and Resources

TIM

(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol

Find Related PDB Entry

Find related ligands:

Chemical Details

Chemical Component Summary

Chemical Descriptors

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Related Resource References